Colgate-Palmolive Stock (US1941621039): Bernstein Starts Coverage With a $96 Target

Responsible: ad hoc news Stocks & Analysis Desk. Reviewed prior to publication on June 16, 2026 at 7:14 PM ET. Details in the imprint.

Colgate-Palmolive shares are in focus on Tuesday after market reports said Bernstein initiated coverage on the consumer staples company with an Overweight rating and a $96 price target. The stock was quoted at 78.38 euros on FinanzNachrichten.de at 5:28 PM local time, which pointed to a modest gain of 0.23% in that feed.

Why the new Bernstein note matters

The new rating gives investors a fresh outside view on a name that is usually tracked for steady cash generation rather than dramatic swings. Colgate-Palmolive is listed on the New York Stock Exchange under the ticker CL and is part of the S&P 500, which makes analyst calls on the shares relevant far beyond the household-products aisle.

Bernstein's $96 target sits above the latest euro-denominated quote in the market data provided, although the comparison is only directional because the source quote is in euros and the target is in US dollars. That mismatch matters: it means the move today is about analyst sentiment, not about a direct rerating of a specific US-dollar trading print in the material available here.

Colgate-Palmolive also remains a classic defensive consumer brand with exposure to oral care, personal care, and home care products across global markets. That business mix is one reason analysts often frame the stock around margin stability, brand strength, and pricing power rather than rapid revenue acceleration.

The current setup is therefore less about a single quarter and more about how the market weighs a new bullish research note against an already mature valuation profile. For a large-cap staple, even a fresh initiation can move attention if the target sits clearly above the prevailing quote.

For now, the stock is being driven by an analyst change rather than a new earnings release or corporate event, so the key question is whether other brokers follow Bernstein's lead.

This article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.